Journal Article

Surgical treatment of hypertrophic obstructive cardiomyopathy

F.A. Schoendube

in European Heart Journal Supplements

Published on behalf of European Society of Cardiology

Volume 3, issue suppl_L, pages L26-L31
Published in print October 2001 | ISSN: 1520-765X
Published online October 2001 | e-ISSN: 1554-2815 | DOI:
Surgical treatment of hypertrophic obstructive cardiomyopathy

Show Summary Details


The rationale for surgical treatment of hypertrophic obstructive cardiomyopathy is based on the assumption that dynamical obstruction is mainly caused by a reduction in the left ventricular outflow tract cross-sectional area due to bulging septal myocardial tissue. In this sense, classical myotomy-myectomy is the `gold standard' therapy for patients with severely symptomatic hypertrophic obstructive cardiomyopathy. In my own experience with extended myectomy, more than three-quarters of all long-term survivors are in functional class I or II (New York Heart Association) and overall survival after 18 years (mean follow up 8.1 years) was 68%, with a linearized mortality rate of 1.9% per patient-year. Notably, there was no case of sudden cardiac death during follow up, leading to the assumption that relief from dynamical obstruction is most effective in the prevention of sudden cardiac death in these patients.

Keywords: extended myectomy; hypertrophic obstructive cardiomyopathy; myotomy-myectomy; surgical therapy

Journal Article.  0 words. 

Subjects: Cardiovascular Medicine

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.